Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Rituxan in the Treatment of Polyneuropathies Associated With Serum IgM Autoantibodies

NCT00006072 is registered in ClinicalTrials.gov with National Center for Research Resources (NCRR) as lead sponsor.

NCT NCT00006072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Rituxan in the Treatment of Polyneuropathies Associated With Serum IgM Autoantibodies
Lead sponsor
National Center for Research Resources (NCRR)
Phase
Phase 2
Overall status
Unknown status
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral neuropathy